Recall Z-3135-2026
Nipro Renal Soultions USA, Corporation · initiated August 5, 2026
Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature
Product
Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25
Codes / lots: DCA+200-25 : Lots - NDC5E015(Exp.5/20/2027), NDC5E016(Exp.5/21/2027), NDC5E017(Exp.5/22/2027), NDC5E019(Exp.5/29/2027), NDC5E012(Exp.5/19/2027), NDC5B017(Exp.2/24/2027), NDC5C023(Exp.3/24/2027) DCA+203-25: NDC5C026(Exp.3/27/2027), NDC5L026(Exp.11/17/2027)
Reason for recall
Hemodialysis concentrates contain high endotoxin levels
FDA-determined cause: Process control
Action taken
On August 6, 2026 Nipro Medical Corporation issued a Urgent Medical Device Recall notification via Email. Nipro asked consignees to take the following actions: 1. Immediately examine your inventory for the affected product codes and lot numbers listed on the Recall response form. 2. Immediately segregate, quarantine, and discontinue use or distribution of any affected product in your possession. 3. Do not use, sell, transfer, or distribute affected products. 4. Complete the enclosed Recall Response Form within 10 business days, even if you do not have affected product on hand. 5. Contact Nipro customer service for product return and credit, if applicable. 6. If you distributed affected product, promptly notify your customers, provide them with a copy of this recall notice, and request that they complete and return the response form or equivalent confirmation. 7. Product Return or Disposition: Affected products should remain quarantined until return, destruction, or other documented disposition instructions are provided by Nipro. Please retain all documentation related to product quarantine, return, destruction, or other disposition for recall reconciliation.
Details
- Recall number
- Z-3135-2026
- Initiated
- August 5, 2026
- Posted by FDA
- September 10, 2026
- Product code
- KPO – Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Quantity
- 7,770 cases
- Distribution
- Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
- Recalling firm
- Nipro Renal Soultions USA, Corporation, Lewisberry, PA
Other products in the same recall event
| Recall | Product | Initiated |
|---|---|---|
| Z-3133-2026 Class II | MedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201Hemodialysis concentrates contain high endotoxin levels | 08/05/2026Open, Classified |
| Z-3134-2026 Class II | MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))Hemodialysis concentrates contain high endotoxin levels | 08/05/2026Open, Classified |
| Z-3136-2026 Class II | Citric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)Hemodialysis concentrates contain high endotoxin levels | 08/05/2026Open, Classified |